Shusen Liu was named chief medical officer of GenomiCare Biotechnology. Liu will be responsible for leading the growth of GenomiCare’s partnership, in China and globally, with biotechnology and pharmaceutical companies.
Liu’s roles within global pharmaceutical companies have included senior director and head of Real World Evidence and Epidemiology, BMS China; senior director and head of Real World Evidence, Sanofi China; and director and head, Pharmacoepidemiology Asia Pacific Unit, Center for Observational and Real-World Evidence, MSD China. He has also served as vice president and chief medical evidence officer at Digital China Health.
Liu has served as an editorial board member of Pharmacoepidemiology (Edition II), and chapter author of Practice of Evidence-based Medicine.
